Referred to the House Committee on Energy and Commerce.
This bill adds a new definition for “zootechnical animal food substance” to the Federal Food, Drug, and Cosmetic Act, treats such substances as food additives subject to section 409 premarket regulation, requires petition data showing both safety and that the substance achieves its intended effect, mandates a specific labeling statement, excludes certain substances (e.g., hormones, ionophores, approved animal drugs), and clarifies the Secretary cannot require use of any such substance.
Liberals emphasize food-safety/efficacy oversight; conservatives emphasize regulatory burden.
Relative to its intended legislative type, this bill is a substantive statutory amendment that is well integrated into the existing FD&C Act structure and provides a clear statutory definition and basic procedural adjustments.
This bill adds a new definition for “zootechnical animal food substance” to the Federal Food, Drug, and Cosmetic Act, treats such substances as food additives subject to section 409 premarket regulation, requires petition data showing both safety and that the substance achieves its intended effect, mandates a specific labeling statement, excludes certain substances (e.g., hormones, ionophores, approved animal drugs), and clarifies the Secretary cannot require use of any such substance.
Narrow, technical bill with limited cost is plausible to advance, but definitional disputes, FDA workload, and stakeholder opposition reduce overall prospects.
Relative to its intended legislative type, this bill is a substantive statutory amendment that is well integrated into the existing FD&C Act structure and provides a clear statutory definition and basic procedural adjustments. It lacks an explicit problem statement, detailed evaluation standards, timelines, fiscal acknowledgment, and additional oversight or reporting mechanisms that would support predictable implementation.
Liberals emphasize food-safety/efficacy oversight; conservatives emphasize regulatory burden.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals emphasize food-safety/efficacy oversight; conservatives emphasize regulatory burden.
Likely views the bill as a useful regulatory step that increases oversight of feed additives affecting animal microbiomes and foodborne pathogens.
Supports evidence and labeling requirements but may worry about exclusions and whether the rules will be strict enough on safety, antibiotics, and corporate influence.
Sees the bill as a pragmatic, targeted clarification creating a new regulatory category and data requirements to ensure both safety and efficacy.
Favors evidence-based rulemaking but will watch for administrative burden, timelines, and impacts on farmers and innovators.
Likely views the bill skeptically as an additional federal regulatory layer imposing premarket approval and labeling mandates on feed innovations.
Concerned about increased costs, slower innovation, and federal overreach into agriculture and feed markets.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, technical bill with limited cost is plausible to advance, but definitional disputes, FDA workload, and stakeholder opposition reduce overall prospects.
The bill has not accumulated any surfaced votes yet.
Liberals emphasize food-safety/efficacy oversight; conservatives emphasize regulatory burden.
Narrow, technical bill with limited cost is plausible to advance, but definitional disputes, FDA workload, and stakeholder opposition reduc…
Relative to its intended legislative type, this bill is a substantive statutory amendment that is well integrated into the existing FD&C Act structure and provides a clear statutory definition and basic procedural adjus…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.